Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Revenue

Can-Fite BioPharma had revenue of $202.00K in the half year ending June 30, 2025, a decrease of -48.47%. This brings the company's revenue in the last twelve months to $560.00K, down -16.04% year-over-year. In the year 2024, Can-Fite BioPharma had annual revenue of $674.00K, down -9.29%.

• Revenue (ttm): $560.00K
• Revenue Growth: -16.04%
• P/S Ratio: 25.16
• Revenue / Employee: $112,000
• Employees: 5
• Market Cap: 14.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	674.00K	-69.00K	-9.29%
Dec 31, 2023	743.00K	-67.00K	-8.27%
Dec 31, 2022	810.00K	-43.00K	-5.04%
Dec 31, 2021	853.00K	90.00K	11.80%
Dec 31, 2020	763.00K	-1.27M	-62.45%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.